Shanghai YingLi Pharmaceutical Co. Ltd.

Works in GI & liver · Hematology · Immunology · Metabolic & endocrine · Oncology

Shanghai YingLi Pharmaceutical Co. Ltd. is a clinical trial sponsor. It has 6 active clinical trials with 1,001 planned participants, across 5 therapeutic areas. Since 2021 it has completed 1 trial and stopped 0 early.

Trial track record · since 2021

6Active trials1,001 planned participants
1Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 6 active trials

StageTrialStatus

Questions about Shanghai YingLi Pharmaceutical Co. Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-29.

Approve Suite is not affiliated with Shanghai YingLi Pharmaceutical Co. Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.